Rivoceranib Appears Active in Recurrent, Metastatic Adenoid Cystic Carcinoma
Rivoceranib produced responses whether or not patients had received prior treatment with a VEGFR TKI.
Head and Neck Cancer
Avasopasem Promising for Severe Oral Mucositis During IMRT for Locally Advanced Head and Neck Cancers
Avasopasem manganese provided a clinically meaningful benefit to patients who developed treatment-related severe oral mucositis.
New Standard of Care in Cisplatin-Ineligible Locally Advanced Head and Neck Squamous Cell Carcinoma
Researchers conducted a randomized study to evaluate docetaxel as a radiosensitizer in patients with LAHNSCC who are cisplatin-ineligible.
Weekly Cisplatin Is Better Tolerated in Head and Neck Squamous Cell Carcinoma
Weekly cisplatin plus radiotherapy should be considered standard care in locally advanced head and neck squamous cell carcinoma, according to researchers.
Nimotuzumab May Improve Survival in Nasopharyngeal Carcinoma
Adding nimotuzumab to concomitant chemoradiotherapy may improve 5-year survival in locally advanced nasopharyngeal carcinoma.
Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT
Higher doses of gabapentin are associated with delayed time to first opioid use.
Cancer Risks Increase With Albuminuria
In a Dutch study, each doubling of urine albumin excretion was significantly associated with a 7% increase in overall cancer risk.
Proton Beam Therapy Increasingly Used to Treat Cancers, Even When Evidence of Effectiveness Is Lacking
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
Risk of Neurologic AEs Lower With Immune Checkpoint Inhibitors Than With Other Cancer Therapies
The risk of neurologic adverse events was 41% lower in patients treated with immune checkpoint inhibitors than in patients who received another drug regimen or a placebo.
High Neutrophil-Lymphocyte Ratio Linked to Worse Survival in Head and Neck Cancer
A high neutrophil-lymphocyte ratio appears to be an independent predictor of outcomes for some patients with head and neck cancer.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...